SCHEMBL26317831

SCHEMBL26317831

COc1ccnc2ccc(N3CCCOCC3)cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 2/20 0.51
CDK8 P49336 2/20 0.51
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
THRB P10828 2/20 0.48
PRKDC P78527 6/20 0.47
ALDH1A1 P00352 4/20 0.46
HPGD P15428 2/20 0.46
POLB P06746 1/20 0.46
MET P08581 1/20 0.45
PDE10A Q9Y233 1/20 0.44
MAPT P10636 2/20 0.44
CYP3A4 P08684 2/20 0.44
TSHR P16473 2/20 0.44
CYP2C19 P33261 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24005893 0.95 CCNC (0.55) CCNCCDK8MEN1KMT2ATHRB
SCHEMBL25456835 0.89 CCNC (0.50) CCNCCDK8PRKDCMAPTNPC1
SCHEMBL25491134 0.88 ALDH1A1 (0.56) CCNCCDK8MEN1KMT2AALDH1A1
SCHEMBL24006371 0.88 ALDH1A1 (0.52) CCNCCDK8MEN1KMT2AALDH1A1
SCHEMBL25831270 0.87 ALDH1A1 (0.55) CCNCCDK8MEN1KMT2AALDH1A1
SCHEMBL24010995 0.83 CCNC (0.54) CCNCCDK8MEN1KMT2APRKDC
SCHEMBL24010843 0.83 MAPT (0.53) MEN1KMT2ATHRBALDH1A1HPGD
SCHEMBL25826716 0.82 CCNC (0.51) CCNCCDK8MEN1KMT2AALDH1A1
SCHEMBL24532253 0.82 MAPT (0.54) MEN1KMT2APRKDCALDH1A1POLB
SCHEMBL23999413 0.81 MAPKAPK2 (0.53) CCNCCDK8MEN1KMT2APRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295114-A1 AKT3 MODULATORS AKT3, AKT2, MTOR CCNC 788/4885CDK8 550/4885MEN1 1926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.